JAGUAR HEALTH, INC. Stock Issued During Period, Value, New Issues
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- JAGUAR HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2023-09-30 was $1.43M, a 28460.00% increase year-over-year.
- JAGUAR HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2022-09-30 was $5.00K.
- JAGUAR HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2020-09-30 was $0.00.
- JAGUAR HEALTH, INC. stock issued during period, value, new issues for the quarter ending 2018-12-31 was $0.00.
- JAGUAR HEALTH, INC. stock issued during period, value, new issues for fiscal 2018 was $2.06M.
- JAGUAR HEALTH, INC. stock issued during period, value, new issues for fiscal 2015 was $15.51M.
| Period end | Stock Issued During Period, Value, New Issues 3 month | Stock Issued During Period, Value, New Issues 12 month |
|---|---|---|
| 2023-09-30 | $1.43M 10-Q · filed 2023-11-14 | |
| 2022-09-30 | $5.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-03 | $2.06M 10-K · filed 2020-04-03 |
| 2018-09-30 | -$203.41K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | $3.73M derived: sum of 4 quarters · filed 2017-02-15 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-15 | $3.73M derived: sum of 4 quarters · filed 2017-02-15 |
| 2016-03-31 | $4.13M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | -$400.40K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-15 | $15.51M 10-K · filed 2017-02-15 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |